Supplementary Online Content

Similar documents
Corporate Leadership Forum March Briefing March 11, 2015

China HPAI Situation - Update

Malaria Situation and Control in China

Polio Bulletin 2014 Issue No Week 25 (as of 23 Jun 2014)

Identifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract)

Improving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress

HO Global Influenza Program: Human-Animal Interface Team) PAI Activities FAO/OIE/WHO Tripartite Animal Health Meeting.

Normal Reference Value of Hemoglobin of Middleaged Women and Altitude

What works for suicide?

Research Article Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013

Supplementary Online Content

Hidden and Mobile: A Web-based Study of Migration Patterns of Men Who Have Sex With Men in China

Changing epidemiological patterns of HIV and AIDS in China in the post-sars era identified by the nationwide surveillance system

Survey of commercial Rhodiola products revealed species diversity and

Analysis on Regional Difference of Narcotic Analgesic Medication in China Based on Data of

Diffusion Effect in Fertility Decline in China: Study on Time-Series

Body Mass Index of Male Youths Aged Years of the Han Nationality Living in Different Regions of China

Geographical disparities in treatment and health care costs for end-of-life cancer patients in China: a retrospective study

Department of Agricultural Economics, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000 Gent, Belgium

A survey of national cardiology workforce in China

Supplementary appendix

Tuberculosis prevalence in China, ; a longitudinal analysis of national survey data

Seasonal variation in blood pressure and its relationship with outdoor air temperature in 10 diverse regions of China: the China Kadoorie Biobank

Japanese Encephalitis in Mainland China

Cigarette Sales in China

A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2004)

COMBATING HIV/AIDS IN MAINLAND CHINA: AN EPIDEMIOLOGICAL REVIEW OF PREVENTION AND CONTROL MEASURES

Supplementary appendix

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Influenza at the human-animal interface

months sales presentation Webcast for investors, analysts & media

Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis

National, regional, and global trends in metabolic risk factors. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group

Hepatitis C virus genotypes and subtypes circulating in Mainland China

REVIEW SUMMARY. Reviews in Medical Virology

Association between multiple comorbidities and self-rated health status in middle-aged and elderly Chinese: the China Kadoorie Biobank study

The Rice Culture Theory of Cooperative Behavior: Evidence from Incentivized Decision Making Tasks in China *

eappendix Hand, Foot and Mouth Disease in China: Patterns of Spread and Transmissibility during

2005 Update on the HIV/AIDS Epidemic and Response in China

Title: Analysis of the immunologic status of a newly diagnosed HIV positive population in China

Geographical Variation in Diabetes Prevalence and Detection in China: Multilevel Spatial Analysis of 98,058 Adults DOI: 10.

Urban-rural disparity of overweight/obesity distribution and its potential trend with breast cancer among Chinese women

A spatiotemporal meta-analysis of HIV/ syphilis epidemic among men who have sex with men living in mainland China

In contrast to Western populations, stroke is the leading. Is There a Stroke Belt in China and Why?

Public awareness of malaria at the beginning of a national malaria elimination program in China

Findings- The sample contained participants with a mean age of 55 6 years (SD 9 7), 59 5% of whom were women. 44 7% (95% CI ) of

Explanatory Notes. WHO Diabetes Country Profiles Background

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease

Epidemiological Fact Sheet on HIV and AIDS. Core data on epidemiology and response. China Update

Unhealthy consumption behaviors and their intergenerational persistence: the role of education

Serological and molecular epidemiology of Japanese encephalitis virus infections in swine herds in China,

Review Article Detection rate of psychogenic cough in patients with chronic cough in Chinese hospital: a meta analysis

Supplemental information for

A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China

MSM HIV testing following an online testing intervention in China

Spatiotemporal variations in lung cancer mortality in China between 2006 and 2012: A multilevel analysis

IMMUNITY TO INFLUENZA INFECTION. Unit 7 Paul Thomas Department of Immunology St. Jude Children s Research Hospital

LUZHOU BIO-CHEM TECHNOLOGY LIMITED. 1HFY2006 Results Briefing. August 15, 2006

Attributable Causes of Cancer in China: Fruit and Vegetable

Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China

Surveillance of Hand, Foot, and Mouth Disease in Mainland China ( )

Trends In CVD, Related Risk Factors, Prevention and Control In China

Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China

Impact of macroeconomic status on prehospital management, in-hospital care and functional outcome of acute stroke in China

UPDATE ACUTE CORONARY SYNDROMES. Dr. Wayne Tymchak April 7, 2017

Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey,

Is the Demand for Alcoholic Beverages in Developing Countries Sensitive to Price? Evidence from China

Welcome Message. We look forward to seeing you in Nanjing in Welcome to Nanjing! Sincerely yours,

Tobacco control in China: the dilemma between economic development and health improvement

Spatiotemporal variation in diabetes mortality in China: multilevel evidence from 2006 and 2012

C&? Disorders of haemoglobin in China. variants and some interesting cases of thalassaemia, and in a study on the chemical structure of

CHINA ECONOMIC, POPULATION, NUTRITION, AND HEALTH SURVEY

STANFORD CENTER FOR INTERNATIONAL DEVELOPMENT

Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis

Travel-related infections in mainland China, : an active surveillance study

Dietary Sodium Intake and Urinary Sodium Excretion by Age Groups among Urban Dwellers

Conference Proceedings. Zhou Bei-Fan 1 and the Cooperative Meta-analysis Group of Working Group on Obesity in China 2

Regional Distribution of Different Types of Human Papillomavirus in Cervixes of Chinese Women: A Meta-analysis

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Circadian Rhythms, Sleep and Cognitive Skills. Evidence From an Unsleeping Giant

Yunting Zheng 1,2, Ying Ji 1, Hongbo Dong 3 and Chun Chang 1*

Ying Liang 1* and Peiyi Lu 2

Analysis of scientific collaboration in Chinese psychiatry research

Circadian rhythms, sleep and cognitive skills Evidence from an unsleeping giant

Supplementary File: Online Survey. Men s Heath Study (Final)

Quantifying predictors for the spatial diffusion of avian influenza virus in China

VNN. Newsletter. FAO Viet Nam. African Swine Fever (ASF) Special Edition STRENGTHENING PREPAREDNESS THROUGH PRACTICE. African Swine Fever (ASF) Facts

Supplementary Online Content

Trends in Nasopharyngeal Carcinoma Mortality in China,

The cross-sectional study of serious mental illness in Gansu province, China

Disability, dementia and frailty in later life - mid-life approaches to prevention. Population based approaches to prevention

HIV and Syphilis Prevalence Among Men Who Have Sex With Men: A Cross-Sectional Survey of 61 Cities in China

Human rabies surveillance and control in China,

Cardiovascular disease (CVD) is a major cause of morbidity

Association between metabolic risk factors and cardiovascular disease mortality: population-level analysis in high income countries

Hand, foot, and mouth disease in China, : an epidemiological study

290 Biomed Environ Sci, 2016; 29(4):

S ince the first AIDS case was diagnosed in 1985,

Transcription:

Supplementary Online Content Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open. 2018;1(4):e181271. doi:10.1/jamanetworkopen.2018.1271 efigure 1. Distributions of a) Systolic Blood Pressure, b) Diastolic Blood Pressure, and c) Body Mass Index () in the Study Population efigure 2. Smoothed Conditional Mean of Diastolic Blood Pressure (, mmhg) Given Body Mass Index (, kg/m 2 ), as Fit With an Unadjusted Generative Additive Model, for Various Sociodemographic Subgroups, Each With at Least 5,000 Individuals efigure 3. Histograms and Density Plots of the Spearman s Rank Correlation Coefficient of Body Mass Index With Systolic Blood Pressure (Panels a and b) or With Diastolic Blood Pressure (Panels c and d) for Every Subgroup Defined by Combinations of Covariates efigure 4. Distribution of Systolic Blood Pressure (SBP) for Individuals on Medication Before and After Matching (Panels a and c), and Smoothed Conditional Mean of SBP Given Body Mass Index () Before and After Matching (Panels b and d) efigure 5. Estimates (Red) Extended to the Year 2030 (Blue) Using a Third Order Polynomial etable 1. Characteristics of the Study Population and the Increase in Blood Pressure (mmhg) per 1 kg/m 2 Body Mass Index for Each Subgroup etable 2. Predicted Increase in Body Mass Index and Attributable Increase in Systolic Blood Pressure by 2025, Population Attributable Fraction (PAF), and Estimate for Strokes That Can Be Attributed to the Increase in Body Mass Index in Men etable 3. Predicted Increase in Body Mass Index and Attributable Increase in Systolic Blood Pressure by 2025, Population Attributable Fraction (PAF), and Estimate for Ischemic Heart Disease (IHD) That Can Be Attributed to the Increase in Body Mass Index in Men eappendix 1. Projected Rates of Stroke and Ischemic Heart Disease Attributable to Increasing eappendix 2. Calculation of Population Attributable Fraction ereferences This supplementary material has been provided by the authors to give readers additional information about their work. 2018 Linderman GC et al. JAMA Network Open.

efigure 1. Distributions of a) systolic blood pressure, b) diastolic blood pressure, and c) body mass index () in the study population (a) (b) (c) 400,000 200,000 300,000 300,000 count count 200,000 count 200,000,000,000,000 0 0 0 200 Systolic BP (mmhg) 50 150 200 Diastolic BP (mmhg) 0 10 20 30 40 50 (kg/m^2) 2018 Linderman GC et al. JAMA Network Open. 2

efigure 2. Smoothed conditional mean of diastolic blood pressure (, mmhg) given body mass index (, kg/m 2 ), as fit with an unadjusted generative additive model, for various sociodemographic subgroups, each with at least 5,000 individuals Sex Age Male Female [35,50] (50,] (,70] (70,] Household Income Ethnicity Hukou Education Unclear <10k 10k 50k >50k Han Mongol Hui Tibet Uygher Miao Yi Zhuang Korean Man Dong Tujia Rural Urban Unified Illiterate <Primary Elementary Middle High Vocational Associate Bachelor No answer Occupation Marital Status Province Currently Smoking Farmer Workers Administrators Admin. Clerk Technician Business Bus. Owner Others Retire Unemployed Housework Unknown Unmarried Married Beijing Tianjin Hebei Shanxi InnerMongol Liaoning Jilin Heilongjiang Shanghai Jiangsu Zhejiang Anhui Fujian Jiangxi Shandong Henan Smoking Not Smoking Hubei Hunan Guangdon Guangxi Hainan Chongqin Sichuan Guizhou Yunnan Tibet Shaanxi Gansu Qinghai Ningxia Xinjiang History of Stroke BP Meds No history Has history No meds On meds 2018 Linderman GC et al. JAMA Network Open. 3

efigure 3. Histograms and density plots of the Spearman s rank correlation coefficient of body mass index with systolic blood pressure (panels a and b) or with diastolic blood pressure (panels c and d) for every subgroup defined by combinations of covariates 2018 Linderman GC et al. JAMA Network Open. 4

efigure 4. Distribution of systolic blood pressure (SBP) for individuals on medication before and after matching (panels a and c), and smoothed conditional mean of SBP given body mass index () before and after matching (panels b and d) 2018 Linderman GC et al. JAMA Network Open. 5

efigure 5. estimates (red) extended to the 2030 (blue) using a third order polynomial Male Age: 35 39 19 1990 2000 2010 2020 2030 Male Age: 40 44 19 1990 2000 2010 2020 2030 Male Age: 45 49 19 1990 2000 2010 2020 2030 Male Age: 50 54 19 1990 2000 2010 2020 2030 Male Age: 55 59 19 1990 2000 2010 2020 2030 Male Age: 64 19 1990 2000 2010 2020 2030 Male Age: 65 69 19 1990 2000 2010 2020 2030 Male Age: 70 74 19 1990 2000 2010 2020 2030 Male Age: 75 79 19 1990 2000 2010 2020 2030 Female Age: 35 39 19 1990 2000 2010 2020 2030 Female Age: 40 44 19 1990 2000 2010 2020 2030 Female Age: 45 49 19 1990 2000 2010 2020 2030 Female Age: 50 54 19 1990 2000 2010 2020 2030 Female Age: 55 59 19 1990 2000 2010 2020 2030 Female Age: 64 19 1990 2000 2010 2020 2030 Female Age: 65 69 19 1990 2000 2010 2020 2030 Female Age: 70 74 19 1990 2000 2010 2020 2030 Female Age: 75 79 19 1990 2000 2010 2020 2030 2018 Linderman GC et al. JAMA Network Open. 6

etable 1. Characteristics of the study population and the increase in blood pressure (mmhg) per 1 kg/m 2 body mass index for each subgroup All Group N Mean SBP/ (Std. Dev.) SBP Adj. SBP Adj. 1,727,411 137/81 (20/11) 1.37±0.02 1.15±0.02 0.85±0.01 0.75±0.01 Sex Male 699,700 137/83 (19/11) 1.26±0.03 1.22±0.03 0.94±0.02 0.83±0.02 Female 1,027,711 136/ (21/11) 1.43±0.02 1.07±0.02 0.79±0.01 0.69±0.01 Age [35,50] 569,428 129/ (18/11) 1.52±0.03 1.28±0.03 1.06±0.02 0.88±0.02 (50,] 549,5 137/82 (20/11) 1.43±0.03 1.17±0.03 0.87±0.02 0.74±0.02 (,70] 494,061 143/81 (21/11) 1.24±0.03 1±0.03 0.66±0.02 0.6±0.02 (70,] 114,317 146/ (21/11) 1.11±0.07 0.87±0.07 0.52±0.04 0.5±0.04 Household Income Unclear 158,754 136/81 (20/11) 1.3±0.06 1.15±0.05 0.83±0.03 0.75±0.03 <10k 387,718 138/81 (21/12) 1.32±0.04 1.14±0.03 0.8±0.02 0.72±0.02 10k-50k 953,304 136/81 (20/11) 1.38±0.02 1.12±0.02 0.84±0.01 0.73±0.01 >50k 227,635 134/81 (20/11) 1.6±0.05 1.28±0.04 1.02±0.03 0.85±0.03 Occupation Farmer 841,945 138/81 (21/11) 1.24±0.02 1.08±0.02 0.78±0.01 0.69±0.01 Workers 134,968 132/81 (19/11) 1.61±0.06 1.3±0.06 1.07±0.04 0.88±0.03 Administrators 25,527 131/82 (19/12) 1.73±0.14 1.33±0.14 1.24±0.08 0.93±0.09 Admin. Clerk 31,759 130/81 (19/12) 1.78±0.13 1.32±0.12 1.26±0.07 0.9±0.08 Technician 71,233 130/81 (19/12) 1.78±0.09 1.36±0.08 1.24±0.05 0.94±0.05 Business 43,490 129/ (19/11) 1.67±0.1 1.37±0.1 1.08±0.06 0.88±0.06 Bus. Owner 34,376 131/81 (19/12) 1.6±0.12 1.31±0.11 1.12±0.07 0.9±0.07 Others 56,734 132/81 (19/11) 1.4±0.09 1.14±0.09 0.9±0.05 0.77±0.05 Retire 288,764 139/81 (20/11) 1.42±0.04 1.09±0.04 0.8±0.02 0.68±0.02 Unemployed 24,148 135/82 (20/12) 1.55±0.14 1.19±0.13 1.04±0.08 0.82±0.08 Housework 142,126 138/81 (21/11) 1.37±0.06 1.11±0.06 0.83±0.03 0.74±0.03 Unknown 26,649 135/82 (20/11) 1.37±0.14 1.09±0.13 0.89±0.08 0.74±0.08 2018 Linderman GC et al. JAMA Network Open. 7

Group N Mean SBP/ (Std. Dev.) Ethnicity SBP Adj. SBP Adj. Han 1,534,086 137/81 (20/11) 1.4±0.02 1.16±0.02 0.87±0.01 0.75±0.01 Mongol 6,7 140/85 (21/12) 1.13±0.27 0.95±0.25 0.74±0.15 0.66±0.14 Hui 10,674 135/ (21/12) 1.55±0.21 1.21±0.19 0.88±0.12 0.82±0.12 Tibet 26,825 134/84 (23/14) 0.6±0.11 0.58±0.1 0.42±0.07 0.41±0.06 Uygher 14,073 132/79 (22/13) 1.02±0.15 1.08±0.14 0.76±0.08 0.77±0.08 Miao 16,738 135/ (22/12) 1.15±0.19 1.4±0.18 0.85±0.1 0.9±0.1 Yi 9,707 128/81 (21/12) 1.07±0.23 1.1±0.22 0.84±0.14 0.75±0.14 Zhuang 62,107 134/78 (20/11) 1.53±0.1 1.46±0.09 0.92±0.05 0.82±0.05 Korean 8,531 134/81 (18/10) 1.26±0.26 0.98±0.24 0.68±0.15 0.6±0.14 Man 20,729 141/84 (20/11) 1.58±0.16 1.24±0.15 0.87±0.09 0.76±0.09 Dong 11,256 133/79 (21/10) 1.1±0.24 1.05±0.23 0.77±0.12 0.76±0.12 Tujia 5,878 136/ (22/12) 1.11±0.32 1.24±0.3 0.85±0.17 0.81±0.17 Marital Status Unmarried 143,542 139/81 (21/11) 1.27±0.06 1.05±0.06 0.75±0.03 0.67±0.03 Married 1,583,869 136/81 (20/11) 1.38±0.02 1.16±0.02 0.86±0.01 0.76±0.01 Hukou Rural 951,521 138/81 (21/11) 1.27±0.02 1.1±0.02 0.8±0.01 0.71±0.01 Urban 543,088 135/81 (20/11) 1.6±0.03 1.23±0.03 0.95±0.02 0.81±0.02 Unified 232,625 135/ (20/11) 1.43±0.05 1.15±0.04 0.9±0.03 0.77±0.03 Province Beijing 24,747 138/81 (19/11) 1.27±0.13 1.14±0.12 0.74±0.07 0.7±0.07 Tianjin 34,424 137/82 (20/11) 1.58±0.11 1.11±0.1 0.85±0.06 0.69±0.06 Hebei 33,677 139/83 (21/11) 1.29±0.12 1±0.11 0.81±0.06 0.72±0.06 Shanxi 23,641 138/82 (20/11) 1.42±0.14 1.06±0.13 0.77±0.08 0.65±0.08 Inner Mongolia 70,334 141/85 (21/12) 1.33±0.08 1.1±0.08 0.91±0.05 0.79±0.05 Liaoning 132,0 139/83 (20/11) 1.81±0.07 1.32±0.07 0.93±0.04 0.75±0.04 Jilin 134,300 137/82 (19/10) 1.46±0.06 1.2±0.06 0.82±0.03 0.74±0.03 Heilongjiang 25,124 138/82 (21/12) 1.6±0.15 1.33±0.13 0.95±0.08 0.8±0.08 Shanghai 10,639 133/78 (19/11) 1.47±0.21 1.37±0.19 0.9±0.12 0.81±0.11 Jiangsu 83,437 141/82 (21/11) 1.44±0.08 1.08±0.07 0.82±0.04 0.69±0.04 Zhejiang 131,697 139/81 (19/11) 1.33±0.06 1.14±0.06 0.84±0.04 0.75±0.04 Anhui 24,886 137/81 (21/11) 1.2±0.14 1.2±0.13 0.79±0.07 0.79±0.07 Fujian 20,906 134/ (19/11) 1.3±0.15 1.27±0.14 0.8±0.09 0.8±0.09 2018 Linderman GC et al. JAMA Network Open. 8

Group N Mean SBP/ (Std. Dev.) SBP Adj. SBP Adj. Jiangxi 82,483 137/79 (21/11) 1.31±0.09 1.29±0.08 1±0.05 0.93±0.04 Shandong 83,273 141/83 (19/10) 1.03±0.07 0.9±0.07 0.62±0.04 0.58±0.04 Henan 83,686 136/82 (19/11) 1.33±0.07 1.12±0.07 0.94±0.04 0.84±0.04 Hubei 83,039 138/81 (21/11) 1.15±0.07 0.85±0.07 0.75±0.04 0.62±0.04 Hunan 29,855 136/79 (20/11) 1.45±0.13 1.39±0.12 0.8±0.07 0.75±0.07 Guangdong 14,192 130/77 (19/11) 1.3±0.17 1.27±0.16 0.73±0.1 0.74±0.1 Guangxi 137,883 132/78 (20/11) 1.35±0.06 1.26±0.06 0.88±0.03 0.79±0.03 Hainan 6,921 131/78 (20/11) 1.32±0.26 1.34±0.24 0.88±0.15 0.83±0.14 Chongqing 20,592 134/81 (22/12) 1.41±0.18 1.33±0.16 0.93±0.1 0.89±0.09 Sichuan 84,236 136/ (21/11) 1.16±0.08 1.09±0.08 0.79±0.04 0.75±0.04 Guizhou 73,559 133/ (22/12) 1.27±0.09 1.34±0.09 0.86±0.05 0.83±0.05 Yunnan 76,392 132/ (21/12) 1.19±0.09 1.16±0.08 0.88±0.05 0.77±0.05 Tibet 23,582 134/85 (23/14) 0.56±0.12 0.52±0.11 0.4±0.07 0.38±0.07 Shaanxi 83,173 137/81 (21/12) 1.52±0.09 1.23±0.08 0.9±0.05 0.78±0.05 Gansu 10,516 137/ (22/11) 1.74±0.23 1.54±0.22 0.94±0.12 0.89±0.12 Qinghai 10,556 136/79 (21/12) 1.31±0.24 1.29±0.22 0.76±0.13 0.73±0.13 Ningxia 14,785 136/ (21/12) 1.6±0.19 1.32±0.18 0.88±0.11 0.8±0.11 Xinjiang 58,796 130/79 (20/12) 1.38±0.08 1.18±0.08 0.86±0.05 0.79±0.05 Education Illiterate 229,193 141/81 (22/12) 1.18±0.05 0.96±0.04 0.65±0.02 0.61±0.02 <Primary 87,890 140/81 (21/11) 1.07±0.07 0.93±0.07 0.66±0.04 0.6±0.04 Elementary 444,583 138/81 (20/11) 1.26±0.03 1.11±0.03 0.79±0.02 0.71±0.02 Middle 556,445 135/81 (20/11) 1.47±0.03 1.21±0.03 0.91±0.02 0.79±0.02 High 185,240 134/81 (19/11) 1.61±0.05 1.27±0.05 1.03±0.03 0.84±0.03 Vocational 72,796 133/ (20/11) 1.62±0.09 1.28±0.08 0.98±0.05 0.82±0.05 Associate 77,820 131/81 (19/11) 1.73±0.08 1.3±0.08 1.19±0.05 0.91±0.05 Bachelor 44,668 129/ (19/12) 1.85±0.11 1.35±0.1 1.29±0.06 0.95±0.07 No answer 26,445 136/82 (20/11) 1.36±0.14 1.1±0.13 0.9±0.08 0.74±0.08 Currently Smoking Smoking 337,072 136/83 (20/11) 1.17±0.04 1.19±0.04 0.91±0.02 0.79±0.02 Not Smoking 1,390,339 137/81 (21/11) 1.42±0.02 1.13±0.02 0.85±0.01 0.73±0.01 History of Stroke No history 1,686,749 136/81 (20/11) 1.37±0.02 1.16±0.02 0.85±0.01 0.75±0.01 Has history 40,662 147/84 (21/12) 1±0.12 0.81±0.11 0.65±0.07 0.53±0.06 2018 Linderman GC et al. JAMA Network Open. 9

Group N Mean SBP/ (Std. Dev.) SBP Adj. SBP Adj. BP Meds No meds 1,512,942 134/ (19/11) 1.24±0.02 1.26±0.02 0.82±0.01 0.8±0.01 On meds 214,469 152/87 (20/12) 0.34±0.05 0.36±0.05 0.43±0.03 0.32±0.03 2018 Linderman GC et al. JAMA Network Open. 10

etable 2. Predicted increase in body mass index and attributable increase in systolic blood pressure by 2025, population attributable fraction (PAF), and estimate for strokes that can be attributed to the increase in body mass index in men Age Increase Attributable SBP Increase (mmhg) Men PAF Total Strokes Attributable Strokes (% of total) 35-39 2 71 3 52 0 22 15943 3559 40-44 2 4 17 0 26 884 22879 45-49 2 88 4 42 0 23 743 17531 50-54 2 95 4 50 0 24 213320 50788 55-59 3 00 4 20 0 19 217123 40234-64 3 03 4 07 0 18 271076 48906 65-69 3 02 4 02 0 14 188521 25673 70-74 2 96 3 55 0 12 243903 29561 75-79 2 86 3 44 0 08 167705 13596 Women 35-39 0 96 1 12 0 08 10374 796 40-44 1 04 1 28 0 09 56682 4932 45-49 1 09 1 52 0 09 435 4192 50-54 1 12 1 57 0 09 130487 11748 55-59 1 13 1 49 0 07 136740 9542-64 1 12 1 40 0 07 212786 13990 65-69 1 07 1 10 0 04 150292 5845 70-74 1 01 1 01 0 04 202091 7203 75-79 0 95 0 99 0 02 153356 3594 2018 Linderman GC et al. JAMA Network Open. 11

etable 3 Predicted increase in body mass index and attributable increase in systolic blood pressure by 2025, population attributable fraction (PAF), and estimate for ischemic heart disease (IHD) that can be attributed to the increase in body mass index in men Age Increase Attributable SBP Increase Men PAF Total IHD Attributable IHD (% of total) 35-39 2 71 3 52 0 17 966 16365 40-44 2 4 17 0 19 103291 20084 45-49 2 88 4 42 0 18 117020 20876 50-54 2 95 4 50 0 18 138277 25073 55-59 3 00 4 20 0 14 285950 41262-64 3 03 4 07 0 14 3684 50635 65-69 3 02 4 02 0 11 389135 420 70-74 2 96 3 55 0 1 404935 38894 75-79 2 86 3 44 0 08 399674 30407 Women 35-39 0 96 1 12 0 06 64675 3615 40-44 1 04 1 28 0 06 68614 4359 45-49 1 09 1 52 0 06 90967 5899 50-54 1 12 1 57 0 07 107971 7230 55-59 1 13 1 49 0 05 199416 106-64 1 12 1 40 0 05 268300 13506 65-69 1 07 1 10 0 03 293294 8936 70-74 1 01 1 01 0 03 326865 9107 75-79 0 95 0 99 0 02 390192 8550 2018 Linderman GC et al. JAMA Network Open. 12

eappendix 1 Projected Rates of Stroke and Ischemic Heart Disease Attributable to Increasing To estimate the increase in SBP and cardiovascular outcomes associated with increases in, we first predicted the population mean level in China in 2025. We used age-sex- specific mean of China from 1974 to 2014 obtained from the NCD Risk Factor Collaboration 1 and fit a third order polynomial model to predict in 2025. In each subgroup defined by sex and age (categorized into groups of five s), we used linear regression models to predict BP using and 8 covariates: Hukou, marital status, education-level, occupation, household income, smoking, history of stroke, and province. Using the estimates of in 2025 in each group, and all other covariates held constant, we calculated the average increase in SBP attributable to increasing. We then estimated the population attributable fraction (PAF) of strokes and ischemic heart disease (IHD) in 2025 due to the predicted increase in SBP using methods described elsewhere 2-4. Specifically, we used age- sex-specific relative risk for ischemic stroke 5 and assumed the standard deviation of the SBP in 2025 is the same as the in the current data. We calculated age- sex-specific PAF, and then multiplied PAF by age- sex-specific for incidence of stroke 6 and IHD cases in China in 2013 to calculate the attributable stroke deaths. We estimated the incidence of IHD in China by dividing the number of deaths due to IHD 7 in 2013 by the case fatality rate, as direct estimates of IHD rates in China are not available. Based on historic age-sex-specific mean in China from 1975-2014, the mean from 2014 to 2025 was predicted to rise from 24 9kg/m 2 to 27 8 kg/m 2 in men and from 24 3 kg/m 2 to 25 3 kg/m 2 in women (efigure 5). The predicted increase in mean SBP secondary to this increase in mean is 4 0 mmhg in men and 1 3 mmhg in women. In 2025, 20% of strokes in men and 7 3% of strokes in women would be attributable to this increase in SBP. In 2025, roughly 314,569 of the strokes (men: 252,727, women: 61,842) and 357,538 cases of ischemic heart disease (IHD) (men: 285,676, women: 71,862) would be attributable to this increase in SBP (etables 2 and 3). eappendix 2. Calculation of Population Attributable Fraction For a given age group and sex, we calculated age-sex-specific population attributable fraction (PAF) using the standard formula 8,,,,,,,., is the age-sex specific relative risk of either ischemic stroke or IHD for a unit increase in SBP 5., is the population distribution of SBP for the given age and sex group in 2013 estimated as a Gaussian distribution, whereas, is the population distribution of SBP in 2013 after shifting the mean by the projected increase in SBP to approximate the distribution in 2025., are the minimum and maximum exposure levels which we took to be 70 and 225 mmhg, as BP outside this range is unlikely to be true. We then multiplied the PAF by age- sexspecific for incidence of stroke in China in 2013 to calculate the attributable stroke incidence 6. 2018 Linderman GC et al. JAMA Network Open. 13

ereferences 1. Collaboration NCDRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377-96. 2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR and Andrews KG. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012;3:2224-22. 3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ and Group CRAC. Selected major risk factors and global and regional burden of disease. The Lancet. 2002;3:1347-13. 4. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ and Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS medicine. 2009;6:e0058. 5. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock G, Qiao Q and Lewington S. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PloS one. 2013;8:e65174. 6. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y and Wang Y. Prevalence, Incidence, and Mortality of Stroke in China. Circulation. 2017;135:759-771. 7. Abubakar I, Tillmann T and Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171. 8. Eide GE and Heuch I. Attributable fractions: fundamental concepts and their visualization. Statistical Methods in Medical Research. 2001;10:159-193. 2018 Linderman GC et al. JAMA Network Open. 14